Semaglutide
Ozempic / Wegovy — weekly injection
Overview
GLP-1 receptor agonist. FDA approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Suppresses appetite, slows gastric emptying, and promotes sustained fat loss with a strong cardiovascular safety profile.
Key Benefits
- ✓5–15% average body weight loss
- ✓Clinically proven appetite suppression
- ✓Blood sugar regulation
- ✓Cardiovascular risk reduction (FDA-approved indication)
- ✓Reduced food cravings and improved satiety
Dosing Protocol
How to Use
Always start at 0.25mg for the first 4 weeks regardless of goal. Advance only if the previous dose was well tolerated. Nausea is manageable — eating smaller meals helps.
Titration Schedule
Follow this stepwise dose advancement. Never skip a step.
- Week 10.25mgStarting dose
- Week 50.5mgTitration 1
- Week 91mgTitration 2
- Week 131.7mgTitration 3
- Week 172.4mgMaintenance
The Science
This compound has FDA-backed clinical evidence — review the trial data and prescribing information below.
Get a Prescription
Prescription Required
TelehealthGLP-1 medications require a prescription. Connect with a licensed telehealth provider to get started.
STACK does not sell, prescribe, or dispense medications.
Track Semaglutide with the STACK app
Set dose reminders, monitor your supply, and ask AI questions about your protocol — all in one place.
All content is for informational purposes only. Peptides are research compounds. Consult a licensed healthcare provider before starting any protocol.
STACK may earn a commission when you purchase through our links at no extra cost to you. This never influences our recommendations — we only feature vendors with verified third-party testing and established quality standards.